Taking Fuel From the IBD Fire: S1PR Modulation as an Effective Oral Option for Management of UC

IBD Medications: S1P Modulators by Dr. Raymond CrossПодробнее

When and How to Use 5-ASAs, Antibiotics, and Steroids in IBDПодробнее

FDA approves NEW NOVEL treatments for Ulcerative Colitis | VELSIPITY | OMVOH | Pharmacist ReviewПодробнее

State of the Art: Positioning Therapies in IBDПодробнее

Diagnosis and management of infections in IBD patients on immunomodulators and biologicsПодробнее

When and How to Use Immunomodulators and Biologics in IBDПодробнее

What are S1P Receptor Modulators for Ulcerative Colitis? Part 2Подробнее

Starting and Monitoring S1P Receptor Modulators for Ulcerative Colitis: Part 1Подробнее

PCH Grand Rounds - Precision Medicine for IBD - Dr. Marla DubinskyПодробнее

Practical Considerations for Pregnancy and IBD | UCLA Digestive DiseasesПодробнее

Starting and Monitoring S1P Receptor Modulators for Ulcerative Colitis: Part 2Подробнее

Benefits & Risks of S1P Receptor Modulators: Part 1Подробнее

Starting and Monitoring S1P Receptor Modulators for Ulcerative Colitis: Part 4Подробнее

Ozanimod (Zeposia) - IBD treatments explained by the expertsПодробнее

Improvements in Targeted IBD Management: Innovative Biologics and Small MoleculesПодробнее

What's new in IBD treatment? Gain insights on advances in the medical and dietary management of IBDПодробнее

Management of Inflammatory Bowel Disease Flares in the Emergency Department (Pharmacology CME)Подробнее

Disease monitoring in IBDПодробнее